Biotech
Managing IP: Via Licensing combines with MPEG LA
May 2, 2023 | Go to Managing IP to Read the Article
Read MoreIAM: Via Licensing acquires MPEG LA in patent pool merger first
May 2, 2023 | Go to IAM to Read the Article
Read MoreVia Licensing and MPEG LA Unite to Form Via Licensing Alliance, the Largest Patent Pool Administrator in the Consumer Electronics Industry
Via Licensing and MPEG LA create new collaborative patent licensing organization
Read MoreVia Licensing Alliance Appoints Three New Members to its Board of Directors
Via Licensing and MPEG LA create new collaborative patent licensing organization
Read MoreMPEG LA Announces Peer Reviewed Article Featured in Nucleic Acid Therapeutics
Article Details the Use of Multimeric Oligonucleotides to Improve Intracellular Conjugate Delivery DENVER, CO, US – 2 October 2019 – World technology licensing leader MPEG LA today announced publication of a peer reviewed article in the October 2019 issue of Nucleic Acid Therapeutics on MPEG LA’s proprietary Increscent Therapeutics™ ligand-directed multiple payload oligonucleotide delivery platform. “MPEG…
Read MoreMPEG LA Issues Statement Regarding CRISPR Patent Licensing
DENVER, CO, US – 25 July 2019 – In light of questions asked of MPEG LA regarding recent events that include the announcement by The Broad Institute and MilliporeSigma to offer their own CRISPR License (press release), the commencement of a new patent interference proceeding by the US Patent Office set in motion by a…
Read MoreThe Broad Institute of MIT and Harvard Among Those Participating MPEG LA’s CRISPR-CAS9 Joint Licensing Facilitation
Patent Submissions Continue to be Accepted (DENVER, CO, US – 10 July 2017) – World licensing leader MPEG LA, LLC is pleased to announce that key CRISPR patent holders have submitted patents in response to MPEG LA’s call to participate in the creation of a global CRISPR-Cas9 Joint Licensing Platform and that patent submissions continue to be…
Read MoreKristin Neuman to Speak About MPEG LA’S CRISPR Pool License at NewYorkBIO and AIPLA
(DENVER, CO, US – 10 May 2017) – World licensing leader MPEG LA, LLC today announced that Kristin Neuman, MPEG LA’s Executive Director of Biotechnology Licensing, will speak at New York BIO’s Annual Meeting on May 11 in New York City and at the American Intellectual Property Law Association (AIPLA) Spring Meeting on May 17…
Read MoreMPEG LA Invites CRISPR-CAS9 Patents to be Pooled in a One-Stop License
Accessibility to a multi-user market will maximize CRISPR’s life-enhancing potential (DENVER, CO, US – 25 April 2017) – World licensing leader MPEG LA, LLC today invited holders of CRISPR-Cas9 patents to participate in the creation of a global CRISPR-Cas9 Joint Licensing Platform that will make their groundbreaking technologies widely accessible. “Pooling the foundational CRISPR patent…
Read MoreMPEG LA Initiative to Address CRISPR Licensing
One-stop access will accelerate advances in new medicines, organ transplants and agriculture (DENVER, CO, US – 6 December 2016) – World licensing leader MPEG LA, LLC announced today an initiative to address the need for an efficient one-stop license alternative around CRISPR, a breakthrough technology that enables cellular DNA to be edited quickly and inexpensively.…
Read More